{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:38:23Z","timestamp":1792546703127,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020560","name":"South East Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022293","name":"Direkt\u00f8r Throne Holsts Fond For Ern\u00e6ringsforskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.atherosclerosis.2022.11.022","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T02:20:17Z","timestamp":1670293217000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Use of statins and other lipid-modifying agents across pregnancy: A nationwide drug utilization study in Norway in 2005\u20132018"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8008-0650","authenticated-orcid":false,"given":"Jacob J.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Bogsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten B.","family":"Holven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Retterst\u00f8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit B.","family":"Veier\u00f8d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Nordeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib1","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"O'Connell","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib3","author":"Visseren","year":"2021"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib5","first-page":"140","article-title":"ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib6","series-title":"Legemiddelforbruket i Norge 2016\u20132020. Data fra Grossistbasert legemiddelstatistikk og Reseptregisteret\/Drug Consumption in Norway 2016-2020 - Data from Norwegian Drug Wholesales Statistics and the Norwegian, Legemiddelstatistikk 2021","author":"Sommerschild","year":"2021"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib7","series-title":"Reseptregisterets Statistikkbank\/Summary Statistics from the Norwegian Prescription Database (NorPD)","year":"2021"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib8","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib9","series-title":"Medisinsk F\u00f8dselsregister Statistikkbank\/Summary Statistics from the Medical Birth Registry of Norway","year":"2021"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib10","first-page":"2546","article-title":"[Medical birth registry--an essential resource in perinatal medical research]","volume":"122","author":"Irgens","year":"2002","journal-title":"Tidsskr. Nor. Laegeforen"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","article-title":"The Nordic countries as a cohort for pharmacoepidemiological research","volume":"106","author":"Furu","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients","volume":"122","author":"Bateman","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib13","series-title":"A Language and Environment for Statistical Computing","year":"2019"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib14","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"Journal of Open Source Software"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.41321","article-title":"Perinatal outcomes after statin exposure during pregnancy","volume":"4","author":"Chang","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2018.07.002","article-title":"Statin exposure during first trimester of pregnancy is associated with fetal ventricular septal defect","volume":"269","author":"Lee","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib17","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib18","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pds.1995","article-title":"Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens","volume":"19","author":"Colvin","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/1471-0528.13128","article-title":"Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study","volume":"122","author":"Zomerdijk","year":"2015","journal-title":"BJOG"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2021.02.024","article-title":"Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: a large-scale, cross-sectional study in primary care","volume":"324","author":"Rachamin","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2021.03.016","article-title":"Misperceptions and management of risk: ongoing challenges in women's cardiovascular health","volume":"324","author":"Farukhi","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib22","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1007\/s00125-012-2689-8","article-title":"The diabetic pregnancy and offspring blood pressure in childhood: a systematic review and meta-analysis","volume":"55","author":"Aceti","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib23","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diacare.26.7.2005","article-title":"Population health significance of gestational diabetes","volume":"26","author":"Cheung","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib24","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2125.2007.02907.x","article-title":"Switching statins in Norway after new reimbursement policy: a nationwide prescription study","volume":"64","author":"Sakshaug","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2009.12.057","article-title":"Earlier intervention in the management of hypercholesterolemia: what are we waiting for?","volume":"56","author":"Steinberg","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib28","first-page":"zwab228","article-title":"Treatment goals in familial hypercholesterolaemia\u2014time to consider low-density lipoprotein-cholesterol burden","author":"Langslet","year":"2021","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review","volume":"73","author":"Halpern","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib31","series-title":"Faglig Retningslinje for Svangerskapsomsorgen\/Norwegian National Guideline for Maternity Care","author":"Nasjonal","year":"2018"},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib32","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jclinepi.2017.10.013","article-title":"Self-reported medication use validated through record linkage to national prescribing data","volume":"94","author":"Hafferty","year":"2018","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2022.11.022_bib34","series-title":"Pharmacy-based Medical Record Linkage Systems","first-page":"270","author":"Herings","year":"2012"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022015453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915022015453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:50:57Z","timestamp":1758156657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915022015453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":33,"alternative-id":["S0021915022015453"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.11.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of statins and other lipid-modifying agents across pregnancy: A nationwide drug utilization study in Norway in 2005\u20132018","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}